Sex as an Independent Prognostic Factor in a Population-Based, Non-Small Cell Lung Cancer Cohort
Authors:
Open Access
- 1 January 2013
- journal article
- research article
- Published by Hindawi Limited in Canadian Respiratory Journal
- Vol. 20 (1) , 30-34
Abstract
BACKGROUND: Males with non-small cell lung cancer (NSCLC) tend to experience worse outcomes, as do those with nonadenocarcinoma histology; however, the independent effects of these factors remain unclear.OBJECTIVE: To evaluate the independent effect of sex and histology on mortality in a population of patients with NSCLC.METHODS: All patients with NSCLC in Manitoba from 1985 to 2004 were identified from the Manitoba Cancer Registry. Treatment data were extracted from the Manitoba Health administrative databases and linked to the registry. Cox regression analysis was used to determine the independent effect of sex on survival.RESULTS: A total of 10,908 patients (6665 male, 4243 female) with NSCLC were identified. Females had a median overall survival of 9.4 months versus 6.8 months for males (P<0.001). The adjusted HR for death for males compared with females was 1.13 (95% CI 1.04 to 1.23; P=0.004). Sex modified the effect of surgical treatment on survival (HR 1.26 [95% CI 1.13 to 1.40]; P<0.001). Adenocarcinoma histology modified the effect of sex on survival (HR 1.36 [95% CI 1.24 to 1.50]; P<0.001) when treatment was accounted for.CONCLUSION: Females experienced a significantly better survival rate than males independent of treatment, age, year of diagnosis and histology. This was greatest in surgically treated patients and in those with adenocarcinoma.Keywords
This publication has 25 references indexed in Scilit:
- The influence of sex and histology on outcomes in non-small-cell lung cancer: a pooled analysis of five randomized trialsAnnals of Oncology, 2010
- The Influence of Sex on Efficacy, Adverse Events, Quality of Life, and Delivery of Treatment in National Cancer Institute of Canada Clinical Trials Group Non-small Cell Lung Cancer Chemotherapy TrialsJournal of Thoracic Oncology, 2010
- National comparisons of lung cancer survival in England, Norway and Sweden 2001-2004: differences occur early in follow-upThorax, 2010
- Differential Expression of Biomarkers in Men and WomenSeminars in Oncology, 2009
- The strength of female sex as a prognostic factor in small-cell lung cancer: a pooled analysis of chemotherapy trials from the Manchester Lung Group and Medical Research Council Clinical Trials UnitAnnals of Oncology, 2009
- Survival and Treatment Pattern of Non-small Cell Lung Cancer Over 20 YearsJournal of Thoracic Oncology, 2009
- Gender differences in non-small cell lung cancer: A population-based studyEuropean Journal of Surgical Oncology, 2007
- Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975Annals of Oncology, 2006
- Erlotinib in Previously Treated Non–Small-Cell Lung CancerNew England Journal of Medicine, 2005
- Lung Cancer in WomenJournal of Clinical Oncology, 2005